Kazia Therapeutics KZIA
NASDAQ KZIA
$6.62 -0.33 (-4.75%)
At close: Nov 13, 2026 · 4:00 PM EST

Kazia Therapeutics (KZIA) Gross Profit (2009)

Updated

Kazia Therapeutics' Gross Profit was $2.17 million in FY2011 (year ended Jun 30, 2011), up 21.8% from $1.78 million in FY2010.

Analysis

Kazia Therapeutics (KZIA) Gross Profit (2009) Analysis & Trends

  • Per Business Quant data, Gross Profit in earlier fiscal years was $1.78 million in FY2010 and $6.84 million in FY2009.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn
5 Novartis Ag 306.35 Bn 279.93 Bn -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn
10 Kazia Therapeutics 10.72 Mn -41.65 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2009 1.36 Mn
API Access

Kazia Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=KZIA&period=max&api_key=YOUR_API_KEY